NO980032L - Biologisk aktiv blanding omfattende cyklosporin - Google Patents

Biologisk aktiv blanding omfattende cyklosporin

Info

Publication number
NO980032L
NO980032L NO980032A NO980032A NO980032L NO 980032 L NO980032 L NO 980032L NO 980032 A NO980032 A NO 980032A NO 980032 A NO980032 A NO 980032A NO 980032 L NO980032 L NO 980032L
Authority
NO
Norway
Prior art keywords
cyclosporine
biologically active
phase
specific
active mixture
Prior art date
Application number
NO980032A
Other languages
English (en)
Other versions
NO980032D0 (no
Inventor
Kaare Larsson
Helena Ljusberg-Wahren
Original Assignee
Gs Dev Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gs Dev Ab filed Critical Gs Dev Ab
Publication of NO980032D0 publication Critical patent/NO980032D0/no
Publication of NO980032L publication Critical patent/NO980032L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Dispersion Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Air-Conditioning For Vehicles (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Biologisk aktiv blanding basert på en L2-fase av et spesifikt monoglycerid, et spesifikt triglycerid og en spesifikk polar væske, og et syklosporin som er løst eller dispergert i nevnte L2-fase som den biologisk aktive substans. En fremgangsmåte for fremstilling av nevnte blanding, hvori syklosporinet blir tilsatt til L2-fasen før, under eller etter dannelsen av samme. Anvendelse av nevnte L2-fase for innkapsling av et syklosporin for fremstilling av et oralt administrer- bart preparat for anvendelse som et immunosuppressivt middel.
NO980032A 1995-07-06 1998-01-05 Biologisk aktiv blanding omfattende cyklosporin NO980032L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9502472A SE504582C2 (sv) 1995-07-06 1995-07-06 Cyklosporinkomposition baserad på en L2-fas
PCT/SE1996/000893 WO1997002042A1 (en) 1995-07-06 1996-07-02 Biologically active composition comprising cyclosporine

Publications (2)

Publication Number Publication Date
NO980032D0 NO980032D0 (no) 1998-01-05
NO980032L true NO980032L (no) 1998-03-03

Family

ID=20398887

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980032A NO980032L (no) 1995-07-06 1998-01-05 Biologisk aktiv blanding omfattende cyklosporin

Country Status (12)

Country Link
EP (1) EP0873133B1 (no)
JP (1) JPH11508592A (no)
AT (1) ATE213951T1 (no)
AU (1) AU6374596A (no)
BR (1) BR9609332A (no)
CA (1) CA2226219A1 (no)
CZ (1) CZ1998A3 (no)
DE (2) DE873133T1 (no)
ES (1) ES2123477T3 (no)
NO (1) NO980032L (no)
SE (1) SE504582C2 (no)
WO (1) WO1997002042A1 (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE511313C2 (sv) 1997-01-13 1999-09-06 Gs Dev Ab Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol
WO1999029316A1 (en) 1997-12-10 1999-06-17 Severson, Mary, L. Pharmaceutical compositions containing an omega-3 fatty acid oil
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
US6638522B1 (en) * 1998-12-11 2003-10-28 Pharmasolutions, Inc. Microemulsion concentrate composition of cyclosporin
DE60221287D1 (de) 2001-11-08 2007-08-30 Atrium Medical Corp Intraluminale vorrichtung mit einer ein therapeutisches-mittel enthaltenden beschichtung
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US8367099B2 (en) 2004-09-28 2013-02-05 Atrium Medical Corporation Perforated fatty acid films
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
EP1811935B1 (en) 2004-09-28 2016-03-30 Atrium Medical Corporation Heat cured gel and method of making
US9592324B2 (en) 2006-11-06 2017-03-14 Atrium Medical Corporation Tissue separating device with reinforced support for anchoring mechanisms
US8312836B2 (en) 2004-09-28 2012-11-20 Atrium Medical Corporation Method and apparatus for application of a fresh coating on a medical device
US20060067977A1 (en) 2004-09-28 2006-03-30 Atrium Medical Corporation Pre-dried drug delivery coating for use with a stent
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
AU2006304590A1 (en) 2005-10-15 2007-04-26 Atrium Medical Corporation Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
ES2393814T3 (es) 2007-04-04 2012-12-28 Sigmoid Pharma Limited Una composición farmacéutica oral
ES2530049T3 (es) 2009-05-18 2015-02-26 Sigmoid Pharma Limited Composición que comprende gotas de aceite
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
CN102573802A (zh) 2009-08-12 2012-07-11 希格默伊德药业有限公司 包含聚合物基质和油相的免疫调节组合物
US10322213B2 (en) 2010-07-16 2019-06-18 Atrium Medical Corporation Compositions and methods for altering the rate of hydrolysis of cured oil-based materials
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
JO3337B1 (ar) * 2010-12-13 2019-03-13 Debiopharm Sa تركيبات صيدلية تشمل أليسبوريفير
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
GB201304662D0 (en) 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
JP6716582B2 (ja) * 2014-11-07 2020-07-01 サブリミティ・セラピューティクス・リミテッドＳｕｂｌｉｍｉｔｙ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｉｍｉｔｅｄ シクロスポリンを含む組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2907460A1 (de) * 1978-03-07 1979-09-13 Sandoz Ag Neue resorbierbare galenische kompositionen
SE457693B (sv) * 1986-07-01 1989-01-23 Drilletten Ab Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
CZ1998A3 (cs) 1998-06-17
JPH11508592A (ja) 1999-07-27
AU6374596A (en) 1997-02-05
DE873133T1 (de) 1999-05-06
NO980032D0 (no) 1998-01-05
SE9502472L (sv) 1997-01-07
CA2226219A1 (en) 1997-01-23
SE9502472D0 (sv) 1995-07-06
BR9609332A (pt) 1999-05-25
EP0873133A1 (en) 1998-10-28
DE69619700T2 (de) 2002-10-24
ES2123477T1 (es) 1999-01-16
EP0873133B1 (en) 2002-03-06
ATE213951T1 (de) 2002-03-15
DE69619700D1 (de) 2002-04-11
WO1997002042A1 (en) 1997-01-23
SE504582C2 (sv) 1997-03-10
ES2123477T3 (es) 2002-08-01

Similar Documents

Publication Publication Date Title
NO980032D0 (no) Biologisk aktiv blanding omfattende cyklosporin
CA2221096A1 (en) Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
NO20005431D0 (no) Gelérbare farmasøytiske preparater
ATE421318T1 (de) Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben
DK0580817T3 (da) Farmaceutisk præparat og fremgangsmåde til fremstilling deraf
DK312583A (da) Kortikoidholdigt praeparat til topisk applikation
IE873213L (en) Galenical Formulation
JPS56135416A (en) Pharmaceutical preparation for skin
UA27801C2 (uk) Спосіб одержання сферул одного чи декількох харчових або медикаментозних активних начал
NO175240C (no) Fremgangsmåte for fremstilling av et langsomt frigivende farmasöytisk preparat som omfatter sekundære granuler
KR860000865A (ko) 약제 제형의 제조방법
GR3018064T3 (en) Aqueous phospholipid vesicle dispersion, process for its manufacture and use thereof.
NO965244D0 (no) Farmasöytisk preparat inneholdende et hydrofobt aktivt stoff og et brusesystem, og fremgangsmåte til fremstilling derav
ATE314068T1 (de) Behandlung von seborrhoischer dermatitis
GB2303791A (en) Method of preparing a predetermined active agent stock solution for liposomal microencapsulation of active agents for agricultural uses
WO1997000671A3 (de) Zusammensetzung zur herstellung feindisperser systeme und verfahren zu ihrer herstellung
IE36563B1 (en) New diazepine derivatives and processes for their production
JPS5558203A (en) Hard polyvinyl alcohol gel and its preparation
ES463092A1 (es) Procedimiento de obtencion de los compuestos 8-(1h-tetrazol-5-il)-11h pirido (2,1-b) quinazolin-11-onas, y las sales farmaceuticamente aceptables de acidos y bases de los mis- mos.
ES8504665A1 (es) Metodo de preparar derivados de p-acilaminofenol
JPS54126722A (en) Slow release antibiotic tablet
JPS5659707A (en) Lasting antibiotic pharmaceutical and its preparation
FR2449450A1 (fr) Nouvelles compositions pharmaceutiques utilisables pour le traitement de l'hypertension
JPS5257390A (en) Immobilized enzyme and method of preparing the same
JPS52145592A (en) Immobilization of enzymes of microbial cells